美《医学新闻周刊》第13卷第20期(1981年)报道:一种新的β-内酰胺抗菌素——Moxalactam已由礼来和日本盐野义公司制成,预示抗微生物的化学疗法将进入一个新的时代。这种药物是在环中有一氧原子,而头孢菌素的环中有一硫键,因此增加此药对需氧菌和厌氧菌的特异抗菌活性,这二种细菌可引起许多外科方面的感染。在伦敦的药物讨论会的记者招待会上,亚特兰大的埃默里大学的外科教授斯通(Harlan Stone)报告了他的研究结果,包括了290名病 US Medical Newsweek Volume 13, Number 20 (1981) reports that a new beta-lactam antibiotic, Moxalactam, has been made by Eli Lilly and Yoshinoya Yasushi, suggesting that antimicrobial chemotherapy would Into a new era. This drug has an oxygen atom in the ring and a sulfur bond in the cephalosporin ring, thus increasing the specific antimicrobial activity of this drug to both aerobic and anaerobic bacteria, which can cause many surgical infections . At a press conference in London’s drug symposium, Harlan Stone, a professor of surgery at Emory University in Atlanta, reported on his findings, which included 290 patients